Skye Bioscience Inc (SKYE)
12.05
-0.20
(-1.63%)
USD |
NASDAQ |
May 17, 16:00
12.05
0.00 (0.00%)
Pre-Market: 20:00
Skye Bioscience Cash from Investing (Quarterly): 1.142M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.142M |
| December 31, 2023 | -0.007M |
| September 30, 2023 | 1.073M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 5.530M |
| December 31, 2022 | 5.666M |
| September 30, 2022 | -0.3661M |
| June 30, 2022 | -0.084M |
| March 31, 2022 | -0.002M |
| December 31, 2021 | -0.054M |
| September 30, 2021 | -0.0267M |
| June 30, 2021 | 0.0005M |
| March 31, 2021 | -0.0107M |
| December 31, 2020 | -0.0072M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.0033M |
| March 31, 2018 | -0.0011M |
| December 31, 2017 | -0.0197M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.0111M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -0.002M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| July 31, 2014 | -0.0678M |
| April 30, 2014 | 0.00 |
| January 31, 2014 | 0.00 |
| October 31, 2013 | 0.00 |
| July 31, 2013 | 0.011M |
| April 30, 2013 | -0.0016M |
| January 31, 2013 | -0.0475M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.3661M
Minimum
Sep 2022
5.666M
Maximum
Dec 2022
0.7562M
Average
--
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Cutera Inc | -0.278M |
| Medical Marijuana Inc | -- |
| OrthoPediatrics Corp | -3.679M |
| RAPT Therapeutics Inc | 15.89M |
| NovaBay Pharmaceuticals Inc | 1.068M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.708M |
| Cash from Financing (Quarterly) | 85.65M |
| Free Cash Flow | -14.61M |
| Free Cash Flow Per Share (Quarterly) | -0.1683 |
| Free Cash Flow Yield | -9.31% |